EXINI SOFTWARE BRINGS ADDED VALUE TO NEW TECHNOLOGY


Lund, Sweden, 2011-10-18 15:58 CEST (GLOBE NEWSWIRE) --  

Alcyone™, a new technology developed by GE Healthcare, reduces the scanning time for cardiac diagnostics while improving image quality. At the newly opened clinic, Nuklearmedizin Wandsbek Markt where EXINI heart™ already is installed, the new Alcyone™ technology will be used. Together with EXINI heart™ this will provide increased capacity to the clinic by automatic interpretation and automated reports.

The clinic Nuklearmedizin Wandsbek Markt opened in mid-September. Their goal is to become one of the most prominent clinics in Europe within cardiac diagnostics. To achieve this, the clinic has installed the latest technology on the market - Alcyone™ from GE Healthcare. The new equipment enables to reduce the scanning time by up to two thirds, while the radioactive dose can be reduced significantly.

EXINI heart™ has been installed at the clinic and the two systems together provide an increased capacity by automatic interpretation and automated reports in German. EXINI employees will be on location in Wandsbek by the end of October to improve the production flow further.

Read more about the Alcyone technology

http://www.gehealthcare.com/

 

For more information, please contact:
Magnus Aurell, CEO
Phone: +46 46 286 54 25
E-mail: magnus.aurell@exini.com

 

 

About EXINI Diagnostics AB (publ)
EXINI Diagnostics AB (publ) offers advanced solutions for medical decision support to hospitals worldwide. The system is based on advanced image analysis by artificial intelligence and can make its  own interpretation of radiology images and provide diagnostic suggestions. In this way the system is used as a decision support for the diagnosing doctor. EXINI is working with products for the diagnosis of some of the most frequent endemic diseases such as coronary heart disease, cancer, dementia and Parkinson's disease. The company was founded in 1999 by Professor Lars Edenbrandt and currently has 13 employees. EXINI is listed on the stock market square and has about 400 shareholders. Principal owner is Bo Håkansson.

         ________________________________________________________________________
         EXINI Diagnostics AB, Ideon Science Park, Scheelevägen 19A, SE-223 70 Lund, Sweden
         Phone: +46 46 286 54 20, Fax: +46 46 286 54 29, info@exini.com, www.exini.com

GlobeNewswire